Amubarvimab - HY-P99435
Nur noch %1 verfügbar
Catalog #
HY-P99435
Ab
362,00 €
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P99435/Amubarvimab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | COVID-19-anti-virus |
| Alternative Names | BRII-196 |
| CAS | 2509447-07-6 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | H2O |
| Clinical Information | Phase 3 |
| Target | SARS-CoV |
| Application: | COVID-19-anti-virus |
|---|